Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of ABVC BioPharma Inc (NASDAQ: ABVC) was $1.59 for the day, up 7.43% from the previous closing price of $1.48. In other words, the price has increased by $7.43 from its previous closing price. On the day, 5.28 million shares were traded. ABVC stock price reached its highest trading level at $1.73 during the session, while it also had its lowest trading level at $1.36.
Ratios:
Our analysis of ABVC’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.28 and its Current Ratio is at 0.28. In the meantime, Its Debt-to-Equity ratio is 0.28 whereas as Long-Term Debt/Eq ratio is at 0.05.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ABVC now has a Market Capitalization of 16791036 and an Enterprise Value of 18802466. For the stock, the TTM Price-to-Sale (P/S) ratio is 111.94 while its Price-to-Book (P/B) ratio in mrq is 1.43. Its current Enterprise Value per Revenue stands at 123.351 whereas that against EBITDA is -2.296.
Stock Price History:
The Beta on a monthly basis for ABVC is 0.71, which has changed by -0.76617646 over the last 52 weeks, in comparison to a change of 0.21080327 over the same period for the S&P500. Over the past 52 weeks, ABVC has reached a high of $9.60, while it has fallen to a 52-week low of $0.67. The 50-Day Moving Average of the stock is 32.40%, while the 200-Day Moving Average is calculated to be 4.95%.
Shares Statistics:
ABVC traded an average of 971.26K shares per day over the past three months and 2397240 shares per day over the past ten days. A total of 10.56M shares are outstanding, with a floating share count of 8.68M. Insiders hold about 17.84% of the company’s shares, while institutions hold 1.05% stake in the company. Shares short for ABVC as of 1713139200 were 532979 with a Short Ratio of 0.55, compared to 1710460800 on 105845. Therefore, it implies a Short% of Shares Outstanding of 532979 and a Short% of Float of 6.909999999999999.
Earnings Estimates
On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$0.06. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 1 analysts. It ranges from a high estimate of $300k to a low estimate of $300k. As of the current estimate, ABVC BioPharma Inc’s year-ago sales were $313k
A total of 1 analysts have provided revenue estimates for ABVC’s current fiscal year. The highest revenue estimate was $700k, while the lowest revenue estimate was $700k, resulting in an average revenue estimate of $152k. In the same quarter a year ago, actual revenue was $970k
